Company intelligence / Profile preview

Brillio

Edison, New Jersey, United Statesbrillio.com ↗

Ownership: Private
Development stage: Other

Overview

Brillio delivers digital transformation and consulting services to life sciences and healthcare organizations. It specializes in AI-driven drug discovery support, modernizing clinical trial operations with SaaS/cloud solutions, regulatory compliance automation, data analytics for patient outcomes improvement, and integration of medical device software. The company has been recognized as a major contender in the Everest Group Life Sciences Digital Services PEAK Matrix Assessment 2022. No direct clinical results as it does not run trials itself.

Industry: Drug Discovery Services

Partnerships

Strategic alliances with leading pharmaceutical companies and hospitals globally for technology implementation projects.

Beyond the preview

Go deeper on Brillio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Brillio.

Explore the full profile